FERRARI, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 230
EU - Europa 212
AS - Asia 149
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 595
Nazione #
US - Stati Uniti d'America 223
CN - Cina 70
SE - Svezia 70
SG - Singapore 68
RU - Federazione Russa 46
IT - Italia 26
FI - Finlandia 15
IE - Irlanda 15
DE - Germania 14
BG - Bulgaria 7
CA - Canada 5
CH - Svizzera 5
GB - Regno Unito 4
EU - Europa 3
SK - Slovacchia (Repubblica Slovacca) 3
AT - Austria 2
BE - Belgio 2
CU - Cuba 2
HK - Hong Kong 2
IN - India 2
MY - Malesia 2
PK - Pakistan 2
EG - Egitto 1
FR - Francia 1
IR - Iran 1
JP - Giappone 1
NL - Olanda 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 595
Città #
Ashburn 62
Singapore 45
Lawrence 37
Princeton 37
Shanghai 25
Dublin 15
Moscow 14
Helsinki 13
Milan 8
Dallas 6
Los Angeles 6
Washington 6
Guangzhou 5
Silistra 5
Yverdon-les-Bains 5
Beijing 3
Boardman 3
Borås 3
Shenzhen 3
Andover 2
Bengaluru 2
Diez de Octubre 2
Hong Kong 2
Jiaxing 2
Kazan' 2
Lappeenranta 2
Marblehead 2
Montecchio Maggiore 2
Naushahro Firoz 2
New York 2
Nuremberg 2
Oakville 2
Ottawa 2
Pisa 2
Puchong Batu Dua Belas 2
San Benedetto Ullano 2
Segrate 2
Sofia 2
St Petersburg 2
Vienna 2
Wuxi 2
Baton Rouge 1
Foshan 1
Frankfurt am Main 1
Freiburg 1
Geislingen an der Steige 1
Genoa 1
Hillsboro 1
Jinan 1
Laurel 1
Longueville 1
Mainz 1
Ningbo 1
Perm 1
Rome 1
Santa Clara 1
Secaucus 1
Stuttgart 1
Tokyo 1
Toronto 1
Verdellino 1
Xi'an 1
Totale 366
Nome #
Innovative high-frequency electrotherapy device Rexon-Eye successfully treats Meibomian gland disease patients 25
Substance P and its Inhibition in Ocular Inflammation 24
High Frequency Electrotherapy for the Treatment of Meibomian Gland Dysfunction 23
Symptoms and signs of conjunctivitis as predictors of disease course in COVID-19 syndrome 23
Erratum: The Effect of Aging on Nerve Morphology and Substance P Expression in Mouse and Human Corneas (Invest Ophthalmol Vis Sci., (2018) 59, (5329-5335), 10.1167/iovs.18-24707) 19
Corneal and Epidermal Nerve Quantification in Chemotherapy Induced Peripheral Neuropathy 19
Angiopoietin 2 expression in the cornea and its control of corneal neovascularisation 18
The keratoconus enigma: A review with emphasis on pathogenesis 18
Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series 18
An innovative platform approach for the development of ex-vivo gene therapies for the treatment of lysosomal storage diseases with skeletal involvement 18
Topically Applied Neurokinin-1 Receptor Antagonists to Treat Ocular Surface Inflammation 16
Substance P aggravates corneal epithelial stem cell deficiency 16
A hypothalamic-controlled neural reflex promotes corneal inflammation 16
Innovative radiofrequency electrotherapy significantly reduces cornea perforation in an alkali burn murine model 15
The role of extracellular matrix in mouse and human corneal neovascularization 15
Corneal confocal microscopy reveals trigeminal small sensory fiber neuropathy in amyotrophic lateral sclerosis 13
Double-biguanide therapy for resistant acanthamoeba keratitis 13
Trigeminal stereotactic electrolysis induces dry eye in mice 13
Nerves in the cornea: proper functioning and healing potential 12
A Novel Mouse Model of Acute Ocular Graft-versus-Host Disease 12
TFOS Lifestyle: Impact of lifestyle challenges on the ocular surface 12
In vivo confocal microscopy in goldenhar syndrome: a case report 12
Alkali burn versus suture-induced corneal neovascularization in C57BL/6 mice: An overview of two common animal models of corneal neovascularization 12
IN VIVO CORNEAL CONFOCAL MICROSCOPY IN PATIENTS WITH GUILLAIN-BARRE SYNDROME 12
Quantifying Ocular Surface Inflammation and Correlating It With Inflammatory Cell Infiltration In Vivo: A Novel Method 12
NK1 Receptor Antagonists as a New Treatment for Corneal Neovascularization 12
Safety and Efficacy of Topical Infliximab in a Mouse Model of Ocular Surface Scarring 12
Corneal collagen cross-linking for management of keratoconus in patients affected by Tourette syndrome 11
Future directions in managing aniridia-associated keratopathy 10
Impending corneal perforation after collagen cross-linking for herpetic keratitis 10
Corneal collagen crosslinking and herpetic keratitis Reply 10
Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment 10
Beauveria bassiana Keratitis: A Case Series and Review of Literature 9
Corneal collagen cross-linking in paediatric patients affected by keratoconus 9
Topical application of infliximab (Remicade®) in the treatment of corneal caustication 9
VesselJ: A New Tool for Semiautomatic Measurement of Corneal Neovascularization 9
Topical neurokinin-1 receptor antagonist Fosaprepitant ameliorates ocular graft-versus-host disease in a preclinical mouse model 9
Nutritional and Metabolic Imbalance in Keratoconus 8
Topical formulations of Aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration 8
Neurosensory abnormalities and stability of a mouse model of dry eye disease 8
Topical fosaprepitant for the treatment of ocular pain and inflammation 8
Ocular Surface Injury Induces Inflammation in the Brain: In Vivo and Ex Vivo Evidence of a Corneal-Trigeminal Axis 8
Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study 8
Anterior segment involvement in vitreoretinal lymphoma: Clinical manifestations, molecular findings and in vivo confocal microscopy 8
Substance P/neurokinin-1 receptor pathway blockade ameliorates limbal stem cell deficiency by modulating mTOR pathway and preventing cell senescence 7
Aprepitant Restores Corneal Sensitivity and Reduces Pain in DED 7
Corneal neovascularization and its potential biomarkers in human tears 7
Cultivated limbal epithelial transplantation 7
Tumor Necrosis Factor-alpha Inhibitors as a Treatment of Corneal Hemangiogenesis and Lymphangiogenesis 7
Vitamin D Supplementation Impacts Systemic Biomarkers of Collagen Degradation and Copper Metabolism in Patients With Keratoconus 6
The two-faced effects of nerves and neuropeptides in corneal diseases 6
Managing the ocular surface after glaucoma filtration surgery: an orphan topic 6
Reciprocal Inhibition of Nerves and Neovessels in the Cornea 6
Substance p modulation of human and murine corneal neovascularization 6
Immunity and pain in the eye: focus on the ocular surface 5
Modulating the tachykinin: Role of substance P and neurokinin receptor expression in ocular surface disorders 5
Evaluation of a Post-Operative Therapy Protocol after Epithelium-Off Corneal Cross-Linking in Patients Affected by Keratoconus 5
Tie2-gfp transgenic mouse as a new model to study corneal neovascularization 5
VesselJ: a new tool for automatic measurement of corneal neovascularization ex-vivo 5
Trigeminal stereotactic electrolysis induces dry eye in mice 5
Corneal Angiogenesis, Sensitivity, and Visual Acuity: a Retrospective Study 5
Modulating ocular surface pain through neurokinin-1 receptor blockade 5
Corneal endothelial cell reduction and increased Neurokinin-1 receptor expression in a graft-versus-host disease preclinical model 4
Targeting amyloid-β in glaucoma treatment 4
In vivo evaluation of DSAEK interface with scanning-laser confocal microscopy 4
Topical ranibizumab as a treatment of corneal neovascularization 3
Corrigendum to "Corneal innervation as a window to peripheral neuropathies" [Exp. Eye Res. 113 (2013) 148-150] DOI: 10.1016/j.exer.2013.05.016 3
Totale 705
Categoria #
all - tutte 11.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.823


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 13 0 4 0 0 0 0
2021/202228 0 0 0 7 0 2 0 7 4 7 0 1
2022/2023215 90 31 10 2 1 13 17 6 6 0 32 7
2023/2024225 0 7 32 43 23 31 8 19 2 10 41 9
2024/2025219 135 30 17 27 10 0 0 0 0 0 0 0
Totale 705